Research comparing routes of administration is ongoing and findings are mixed, so the practical difference for any individual patient is a question for their prescribing provider
Yes, it means that its working well but it also means that starting low and slow is important
Like Ozempic, the new pill is designed to mimic the glucagon-like peptide 1 hormone that our bodies produce naturally, albeit in very small, transient doses
Helps convert macronutrients into usable energy, supporting vitality and stamina throughout the day
In the UK, Wegovy is recommended by NICE (Technology Appraisal 875) for adults with at least one weight-related comorbidity and a BMI of at least 35 kg/m, or a BMI between 30-34.9 kg/m with exceptional circumstances
Their combined angiogenic effects are key to improved oxygenation and nutrient delivery during tissue recovery